usa ordering 50 % relenza and lani iv news, page-28

The NIH funding was not specifically for swine flu. This testing might be part of that, or it might be additional to that, it would be likely to be additional as the NIH funding is most likely already spoken for.

The Wilson's report is breathtaking in it's ignorance and use of loaded terms; sales expectations are "heroic" and Relenza is a "wasting asset". How can they be allowed to do this, and also to completely ignore LANI? RBS Morgan was conservative, but much more fair.

I am leaning towards Abobo's sentiments, visualising PC looking on with smug satisfaction as Biota once again becomes a toy for day traders.

The market can stay irrational longer than I can stay solvent, so I am out for now, but sad and angry at Biota's management.